These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18051573)

  • 21. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolation and in vitro characterization of CD133(+) side population cells from laryngeal cancer cell line].
    Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):752-7. PubMed ID: 22177045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Characterization of CD133(pos) Subpopulation Cells From a Human Laryngeal Cancer Cell Line.
    Qiu HO; Wang H; Che N; Li D; Mao Y; Zeng Q; Ge R
    Med Sci Monit; 2016 Apr; 22():1146-51. PubMed ID: 27049928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
    Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 is of functional importance for colorectal cancer stem cells.
    Du L; Wang H; He L; Zhang J; Ni B; Wang X; Jin H; Cahuzac N; Mehrpour M; Lu Y; Chen Q
    Clin Cancer Res; 2008 Nov; 14(21):6751-60. PubMed ID: 18980968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
    Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
    Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.
    Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
    Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
    Wei X; He J; Wang J; Yang X; Ma B
    Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
    Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
    Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
    Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
    Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.
    Chen XH; Bao YY; Zhou SH; Wang QY; Wei Y; Fan J
    Mol Med Rep; 2013 Dec; 8(6):1695-700. PubMed ID: 24146103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
    Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
    Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.
    Suetsugu A; Nagaki M; Aoki H; Motohashi T; Kunisada T; Moriwaki H
    Biochem Biophys Res Commun; 2006 Dec; 351(4):820-4. PubMed ID: 17097610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carcinogenicity study of CD133(+)CD44(+) laryngeal cancer stem cells and identification of related microRNAs].
    Li Y; Zhou XH; Chen ZH; Dai LL; Cui CX; Wu HL; Wei QY; Fan KM; Xu YL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):529-533. PubMed ID: 31315361
    [No Abstract]   [Full Text] [Related]  

  • 38. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
    de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
    APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.